8-K2.029.01
8-K exhibit
EDGARKrystal Biotech Inc (KRYS) SEC filings
Krystal Biotech Inc (KRYS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported KRYS revenue for 2025-09-30 was $97.8M. Net income was $79.4M. Revenue was up 1.8% from 2025-06-30 to 2025-09-30. KRYS currently screens at market cap $10.17B and trailing P/E 46.1. The KRYS filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Krystal Biotech Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
3
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all KRYS filings.
Frequently asked questions
What did KRYS just say?
KRYS cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are KRYS SEC filings?
3 cached filings are on this page. EDGAR remains the official archive (CIK 0001711279).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.